Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II AT1 receptor

被引:46
|
作者
Ali, MS [1 ]
Sayeski, PP [1 ]
Bernstein, KE [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M908931199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin II activates the Jak-STAT pathway via the AT(1) receptor. We studied two mutant AT(1) receptors, termed M5 and M6, that contain Y to F substitutions for the tyrosine residues naturally found in the third intracellular loop and the carboxyl terminus. After binding ligand, both the M5 and M6 AT(1) receptors trigger STAT1 tyrosine phosphorylation equivalent to that observed with the wild type receptor, indicating that angiotensin II-mediated phosphorylation of STAT1 is independent of these receptor tyrosine residues. In response to angiotensin II, Jak2 autophosphorylates on tyrosine, and Jak2 and STAT1 physically associate, a process that depends on the SH2 domain of STAT1 in vitro. Evaluation of the wild type, M5, and M6 AT(1) receptors showed that angiotensin II-dependent AT(1) receptor-Jak2-STAT1 complex formation is dependent on catalytically active Jak2, not on the receptor tyrosine residues in the third intracellular loop and carboxyl tail. Immunodepletion of Jak2 virtually eliminated the ligand-dependent binding of STAT1 to the AT(1) receptor. These data indicate that the association of STAT1 with the AT(1) receptor is not strictly bimolecular; it requires Jak2 as both a STAT1 kinase and as a molecular bridge linking STAT1 to the AT(1) receptor.
引用
收藏
页码:15586 / 15593
页数:8
相关论文
共 50 条
  • [1] The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes
    McWhinney, CD
    Hunt, RA
    Conrad, KM
    Dostal, DE
    Baker, KM
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (09) : 2513 - 2524
  • [2] STAT1 activation in association with JAK2 exon 12 mutations
    Godfrey, Anna L.
    Chen, Edwin
    Massie, Charles E.
    Silber, Yvonne
    Pagano, Francesca
    Bellosillo, Beatriz
    Guglielmelli, Paola
    Harrison, Claire N.
    Reilly, John T.
    Stegelmann, Frank
    Bijou, Fontanet
    Lippert, Eric
    Boiron, Jean-Michel
    Doehner, Konstanze
    Vannucchi, Alessandro M.
    Besses, Carlos
    Green, Anthony R.
    HAEMATOLOGICA, 2016, 101 (01) : E15 - E19
  • [3] Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase
    Zhu, XJ
    Wen, ZL
    Xu, LZ
    Darnell, JE
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (11) : 6618 - 6623
  • [4] The Jak2 protein motif, 231YRFRR, mediates the angiotensin II-dependent nuclear accumulation of Stat1
    Sayeski, PP
    Ali, MS
    Frank, SJ
    Bernstein, KE
    HYPERTENSION, 2001, 38 (03) : 487 - 487
  • [5] JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription
    Han, YL
    Watling, D
    Rogers, NC
    Stark, GR
    MOLECULAR ENDOCRINOLOGY, 1997, 11 (08) : 1180 - 1188
  • [6] Regulation of STAT1 nuclear export by Jak1
    Mowen, K
    David, M
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (19) : 7273 - 7281
  • [7] Constitutive JAK2/STAT1 activation regulates endogenous BACE1 expression in neurons
    Cho, Hyun Jin
    Jin, Seok Min
    Son, Sung Min
    Kim, Yong Woo
    Hwang, Ji Yeon
    Hong, Hyun Seok
    Mook-Jung, Inhee
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (01) : 175 - 180
  • [8] OTUB1 Promotes Glioblastoma Growth by Inhibiting the JAK2/STAT1 Signaling Pathway
    Yang, Jun
    Zhang, Na
    He, Zesong
    Xiong, Junyi
    Meng, Wei
    Xue, Chengcheng
    Ying, Li
    Li, Meihua
    Liu, Mei
    Ouyang, Taohui
    JOURNAL OF CANCER, 2024, 15 (14): : 4566 - 4576
  • [9] STAT1 acts as a tumor promoter for leukemia development
    Kovacic, Boris
    Stoiber, Dagmar
    Moriggl, Richard
    Weisz, Eva
    Ott, Rene G.
    Kreibich, Rita
    Levy, David E.
    Beug, Hartmut
    Freissmuth, Michael
    Sexl, Veronika
    CANCER CELL, 2006, 10 (01) : 77 - 87
  • [10] Interleukin 3 activates not only JAK2 and STAT5, but also Tyk2, STAT1, and STAT3
    Nagata, Y
    Todokoro, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (03) : 785 - 789